journal article·2023-03-28Open access

Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles

Eride Quarta, Michele Chiappi, Alessio Adamiano, Anna Tampieri, Weijie Wang, Teresa D. Tetley, Francesca Buttini, Fabio Sonvico, Daniele Catalucci, Paolo Colombo, Michele Iafisco, Lorenzo Degli Esposti

Abstract

Recently, there has been increasing interest in developing biocompatible inhalable nanoparticle formulations, as they have enormous potential for treating and diagnosing lung disease. In this respect, here, we have studied superparamagnetic iron-doped calcium phosphate (in the form of hydroxyapatite) nanoparticles (FeCaP NPs) which were previously proved to be excellent materials for magnetic resonance imaging, drug delivery and hyperthermia-related applications. We have established that FeCaP NPs are not cytotoxic towards human lung alveolar epithelial type 1 (AT1) cells even at high doses, thus proving their safety for inhalation administration. Then, D-mannitol spray-dried microparticles embedding FeCaP NPs have been formulated, obtaining respirable dry powders. These microparticles were designed to achieve the best aerodynamic particle size distribution which is a critical condition for successful inhalation and deposition. The nanoparticle-in-microparticle approach resulted in the protection of FeCaP NPs, allowing their release upon microparticle dissolution, with dimensions and surface charge close to the original values. This work demonstrates the use of spray drying to provide an inhalable dry powder platform for the lung delivery of safe FeCaP NPs for magnetically driven applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inhalation and Respiratory Drug Delivery · Microencapsulation and Drying Processes · Aerosol Filtration and Electrostatic Precipitation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy

National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 0AZ, UK

Institute of Science, Technology and Sustainability for Ceramic Materials (ISSMC), National Research Council (CNR), Via Granarolo 64, 48018 Faenza, Italy

Interdepartmental Center for Innovation in Health Products, Biopharmanet_TEC, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy

Institute of Genetic and Biomedical Research (IRGB), National Research Council (CNR), UOS Milan and IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy

PlumeStars srl, Parco Area Delle Scienze, 27/A, 43125 Parma, Italy

Funding

European Union

References (38)

Show source-provided references
1. Nanoparticles in medicine: Therapeutic applications and developments10.1038/sj.clpt.6100400 ↗
2. Targeted delivery of nanoparticles for the treatment of lung diseases10.1016/j.addr.2007.11.006 ↗
3. Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases10.1016/j.jddst.2023.104261 ↗
4. Trojan particles: Large porous carriers of nanoparticles for drug delivery10.1073/pnas.182233999 ↗
5. Formulation strategy and use of excipients in pulmonary drug delivery10.1016/j.ijpharm.2010.03.017 ↗
6. Quarta, E., Sonvico, F., Bettini, R., De Luca, C., Dotti, A., Catalucci, D., Iafisco, M., Degli Esposti, L., Colombo, G., and Trevisi, G. (2021). Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design. Pharmaceutics, 13.10.3390/pharmaceutics13111825 ↗
7. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system10.1016/j.jmmm.2005.01.064 ↗
8. Magnetic biohybrid microrobot multimers based on chlorella cells for enhanced targeted drug delivery10.1021/acsami.1c16859 ↗
9. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging10.1016/j.biomaterials.2008.07.004 ↗
10. Magnetic calcium phosphates nanocomposites for the intracellular hyperthermia of cancers of bone and brain10.2217/nnm-2018-0372 ↗
11. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying10.1016/j.ijpharm.2014.12.050 ↗
12. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung10.1016/j.ejpb.2013.09.004 ↗
13. In vivo pulmonary delivery and magnetic-targeting of dry powder nano-in-microparticles10.1021/acs.molpharmaceut.7b00532 ↗
14. Development of inhalable superparamagnetic iron oxide nanoparticles (SPIONs) in microparticulate system for antituberculosis drug delivery10.1002/adhm.201800124 ↗
15. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)10.3402/nano.v1i0.5358 ↗
16. Inhaled fluorescent magnetic nanoparticles induced extramedullary hematopoiesis in the spleen of mice10.1539/joh.L8159 ↗
17. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments10.1002/jat.1779 ↗
18. Iron overload by superparamagnetic iron oxide nanoparticles is a high risk factor in cirrhosis by a systems toxicology assessment10.1038/srep29110 ↗
19. Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite10.1016/j.actbio.2011.09.032 ↗
20. Fe-doping-induced magnetism in nano-hydroxyapatites10.1021/acs.inorgchem.6b03143 ↗
21. Superparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicin10.1039/C5TB01524C ↗
22. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging10.1016/j.actbio.2018.04.040 ↗
23. Magnetic labelling of mesenchymal stem cells with iron-doped hydroxyapatite nanoparticles as tool for cell therapy10.1166/jbn.2016.2248 ↗
24. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults10.1111/j.1440-1843.2012.02189.x ↗
25. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake10.1165/rcmb.2007-0334OC ↗
26. Markossian, S., Grossman, A., and Brimacombe, K. (2004). Cell Viability Assays, Assay Guidance Manual.
27. Coelho, A. (2012). Topas Academic V5. Coelho Softw.
28. Structural variations in natural F, OH, and Cl apatites
29. Three polymorphs (α, β, and δ) of D-mannitol at 100 K10.1107/S0108270103018961 ↗
30. Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium10.1021/nn505399e ↗
31. Translocation of functionalized multi-walled carbon nanotubes across human pulmonary alveolar epithelium: Dominant role of epithelial type 1 cells10.1021/acsnano.5b08218 ↗
32. Heat capacities and nonisothermal thermal decomposition reaction kinetics of D-mannitol10.1021/je900285w ↗
33. Pharmaceutical particle engineering via spray drying10.1007/s11095-007-9475-1 ↗
34. Lechanteur, A., and Evrard, B. (2020). Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: A review. Pharmaceutics, 12.10.3390/pharmaceutics12010055 ↗
35. Influence of particle size on regional lung deposition–what evidence is there?10.1016/j.ijpharm.2010.12.040 ↗
36. Fundamental effects of particle morphology on lung delivery: Predictions of Stokes’ law and the particular relevance to dry powder inhaler formulation and development10.1023/A:1014426530935 ↗
37. Bisgaard, H., O’Callaghan, C., and Smaldone, G.C. (2001). Drug Delivery to the Lung, CRC Press.10.1201/b14022 ↗
38. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer10.1016/j.colsurfb.2009.02.001 ↗